[Clinical effects of stearyl-ara-CMP (YNK-01) on chronic hematologic malignancies].
Im
T
T
Dept. of Laboratory Medicine, Osaka City University Medical School, Japan.
Ota
K
K
Ohira
H
H
Yasui
Y
Y
Nakao
Y
Y
Furukawa
Y
Y
Inoue
K
K
Yamane
T
T
Hiyoshi
M
M
Kishida
T
T
D000328:Adult; D000368:Aged; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D001088:Arabinonucleotides / Q000627:therapeutic use*; D002908:Chronic Disease; D003568:Cytidine Monophosphate / Q000031:analogs & derivatives* / Q000627:therapeutic use; D004341:Drug Evaluation; D005260:Female; D006801:Humans; D007938:Leukemia / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D009101:Multiple Myeloma / Q000188:drug therapy; D009190:Myelodysplastic Syndromes / Q000188:drug therapy; D012074:Remission Induction
D000970:Antineoplastic Agents; D001088:Arabinonucleotides; C061162:1-arabinofuranosylcytosine-5'-stearylphosphate; D003568:Cytidine Monophosphate